NFH 621 Test #2 Respiratory with
complete solutions latest version
What .is .the .definition .of .asthma? .- .CORRECT .ANSWER-airway .inflammation,
.intermittent .airflow .obstruction .secondary .to .increase .smooth .muscle .tone .and
.bronchial .hyperresponsiveness
what .are .some .predisposing .factors .of .asthma? .- .CORRECT .ANSWER-age,
.family .history, .exposure .to .workplace .dust, .animal .products, .GERD, .smoking,
.obesity
what .are .signs/symptoms .of .asthma? .- .CORRECT .ANSWER-RECURRENT
.COUGH .(worsens .at .night/early .morning), .recurrent .wheezing, .recurrent .SOB,
.recurrent .chest .tightness
common .exam .findings .of .asthma: .- .CORRECT .ANSWER-tachypnea,
.tachycardia, .cyanosis, .use .of .accessory .muscles,wheezing, .hyper .resonance
what .are .some .ways .to .diagnose .asthma? .- .CORRECT .ANSWER-spirometry
.(gold .standard), .CXR, .allergy .testing .(recommended .esp .for .children .with
.persistent .asthma)
characteristics .of .MILD .INTERMITTENT .asthma: .- .CORRECT .ANSWER-
symptoms .< .or .equal .to .2 .per .week
asymptomatic .between .attacks
PM .symptoms .less .than .or .equal .to .2 .per .month
PEFR .>80%
characteristics .of .MILD .PERSISTENT .asthma: .- .CORRECT .ANSWER-symptoms
.>2 .per .week .but .less .than .daily
exacerbations .may .effect .activity
PM .symptoms .>2 .per .month
PEFR .:80%
, characteristics .of .MODERATE .PERSISTENT .asthma: .- .CORRECT .ANSWER-daily
.symptoms .requiring .beta .2 .agonist .use
attacks .affect .activity
>2 .exacerbations .per .week
PM .symptoms .>1 .per .week
PEFR .60-80%
characteristics .of .SEVERE .PERSISTENT .asthma: .- .CORRECT .ANSWER-
continuous .symptoms .with .limited .physical .activity
frequent .exacerbations
frequent .PM .symptoms
PEFR .< .or .equal .to .60%
what .does .it .mean .if .an .asthma .patient .is .using .a .SABA .rescue .inhaler .more
.than .2 .times .per .week? .- .CORRECT .ANSWER-the .patient .has .inadequate
.control .and .needs .inhaled .corticosteroid .(ICS) .as .controller .therapy
what .is .the .treatment .for .mild .(step .1) .asthma? .- .CORRECT .ANSWER-no .long
.term .preventive .medications
use .SABAs, .can .be .used .up .to .4x .a .day .to .treat .exacerbations
what .is .the .treatment .for .mild .to .moderate .(step .2) .asthma? .- .CORRECT
.ANSWER-low .dose .ICS .used .daily .(+rescue .inhaler)
budesonide .(pulmicort)<-- .only .inhaler .approved .for .infants .and .children .<4 .yos
what .is .the .treatment .for .moderate .(step .3) .asthma? .- .CORRECT .ANSWER-
consider .referral .to .asthma .specialist
use .ICS .+ .long .acting .beta .2 .agonist .(LABA) .OR .medium .dose .ICS
what .is .the .treatment .for .moderate .to .severe .(step .4) .asthma? .- .CORRECT
.ANSWER-medium .to .high .ICS .dose .+ .either .LABA .or .Montelukast
medium .dose .ICS .+ .either .a .leukotriene .modifier .or .theophylline
what .is .the .treatment .for .severe .(step .5/6) .asthma? .- .CORRECT .ANSWER-high
.dose .ics .+ .LABA .and .consider .omalizumab .for .patients .with .allergies
complete solutions latest version
What .is .the .definition .of .asthma? .- .CORRECT .ANSWER-airway .inflammation,
.intermittent .airflow .obstruction .secondary .to .increase .smooth .muscle .tone .and
.bronchial .hyperresponsiveness
what .are .some .predisposing .factors .of .asthma? .- .CORRECT .ANSWER-age,
.family .history, .exposure .to .workplace .dust, .animal .products, .GERD, .smoking,
.obesity
what .are .signs/symptoms .of .asthma? .- .CORRECT .ANSWER-RECURRENT
.COUGH .(worsens .at .night/early .morning), .recurrent .wheezing, .recurrent .SOB,
.recurrent .chest .tightness
common .exam .findings .of .asthma: .- .CORRECT .ANSWER-tachypnea,
.tachycardia, .cyanosis, .use .of .accessory .muscles,wheezing, .hyper .resonance
what .are .some .ways .to .diagnose .asthma? .- .CORRECT .ANSWER-spirometry
.(gold .standard), .CXR, .allergy .testing .(recommended .esp .for .children .with
.persistent .asthma)
characteristics .of .MILD .INTERMITTENT .asthma: .- .CORRECT .ANSWER-
symptoms .< .or .equal .to .2 .per .week
asymptomatic .between .attacks
PM .symptoms .less .than .or .equal .to .2 .per .month
PEFR .>80%
characteristics .of .MILD .PERSISTENT .asthma: .- .CORRECT .ANSWER-symptoms
.>2 .per .week .but .less .than .daily
exacerbations .may .effect .activity
PM .symptoms .>2 .per .month
PEFR .:80%
, characteristics .of .MODERATE .PERSISTENT .asthma: .- .CORRECT .ANSWER-daily
.symptoms .requiring .beta .2 .agonist .use
attacks .affect .activity
>2 .exacerbations .per .week
PM .symptoms .>1 .per .week
PEFR .60-80%
characteristics .of .SEVERE .PERSISTENT .asthma: .- .CORRECT .ANSWER-
continuous .symptoms .with .limited .physical .activity
frequent .exacerbations
frequent .PM .symptoms
PEFR .< .or .equal .to .60%
what .does .it .mean .if .an .asthma .patient .is .using .a .SABA .rescue .inhaler .more
.than .2 .times .per .week? .- .CORRECT .ANSWER-the .patient .has .inadequate
.control .and .needs .inhaled .corticosteroid .(ICS) .as .controller .therapy
what .is .the .treatment .for .mild .(step .1) .asthma? .- .CORRECT .ANSWER-no .long
.term .preventive .medications
use .SABAs, .can .be .used .up .to .4x .a .day .to .treat .exacerbations
what .is .the .treatment .for .mild .to .moderate .(step .2) .asthma? .- .CORRECT
.ANSWER-low .dose .ICS .used .daily .(+rescue .inhaler)
budesonide .(pulmicort)<-- .only .inhaler .approved .for .infants .and .children .<4 .yos
what .is .the .treatment .for .moderate .(step .3) .asthma? .- .CORRECT .ANSWER-
consider .referral .to .asthma .specialist
use .ICS .+ .long .acting .beta .2 .agonist .(LABA) .OR .medium .dose .ICS
what .is .the .treatment .for .moderate .to .severe .(step .4) .asthma? .- .CORRECT
.ANSWER-medium .to .high .ICS .dose .+ .either .LABA .or .Montelukast
medium .dose .ICS .+ .either .a .leukotriene .modifier .or .theophylline
what .is .the .treatment .for .severe .(step .5/6) .asthma? .- .CORRECT .ANSWER-high
.dose .ics .+ .LABA .and .consider .omalizumab .for .patients .with .allergies
